Format

Send to

Choose Destination
EMBO Mol Med. 2014 Jun;6(6):708-20. doi: 10.1002/emmm.201403876. Epub 2014 Apr 6.

Vaccines for the 21st century.

Author information

1
Novartis Vaccines, Siena, Italy.
2
Novartis Vaccines, Siena, Italy ennio.de_gregorio@novartis.com.

Abstract

In the last century, vaccination has been the most effective medical intervention to reduce death and morbidity caused by infectious diseases. It is believed that vaccines save at least 2-3 million lives per year worldwide. Smallpox has been eradicated and polio has almost disappeared worldwide through global vaccine campaigns. Most of the viral and bacterial infections that traditionally affected children have been drastically reduced thanks to national immunization programs in developed countries. However, many diseases are not yet preventable by vaccination, and vaccines have not been fully exploited for target populations such as elderly and pregnant women. This review focuses on the state of the art of recent clinical trials of vaccines for major unmet medical needs such as HIV, malaria, TB, and cancer. In addition, we describe the innovative technologies currently used in vaccine research and development including adjuvants, vectors, nucleic acid vaccines, and structure-based antigen design. The hope is that thanks to these technologies, more diseases will be addressed in the 21st century by novel preventative and therapeutic vaccines.

KEYWORDS:

adjuvants; clinical trials; infectious diseases; structural vaccinology; vectors

PMID:
24803000
PMCID:
PMC4203350
DOI:
10.1002/emmm.201403876
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center